Connect with us

Technology

ESMO 2024: Stay Informed with Real-Time Coverage and Analysis from DelveInsight

Published

on

As the stage is set for another year of groundbreaking research and transformative treatment advancements, several companies are seizing the opportunity to present their data readouts. DelveInsight’s oncology consultants and analysts will be closely tracking the key oncology abstracts and datasets to watch at ESMO 2024.

LAS VEGAS, Sept. 13, 2024 /PRNewswire/ — The ESMO conference is a key event in the field of oncology, serving as a vital platform for sharing the latest breakthroughs in cancer research and treatment. Held annually, this conference provides a thorough overview of the most recent advancements across various oncology sub-specialties.

As the ESMO 2024 annual meeting approaches, numerous pharmaceutical companies are preparing to present their latest data. DelveInsight invites you to discover the newest developments in oncology research and development.

The DelveInsight team is ready to provide exceptional coverage, engaging with experts and professionals across the oncology field. We will participate in oral abstract presentations, interactive workshops, and poster and educational sessions, all tailored to the specific interests of clinical oncologists and researchers.

Stay tuned with DelveInsight’s analysis of key themes and results at our page: ESMO 2024 Conference

We prioritize industry-sponsored and highly anticipated trial data presentations. Experience the buzz at ESMO 2024 as we analyze key sessions and unveil the latest advancements shaping the future of oncology.

DelveInsight’s ESMO Conference Coverage Solutions will help the client in several ways:

Get data-driven insights generated through interpretation of Key Oral Abstracts presentations inclusive of all relevant Session Types such as Mini Oral, Industry Satellite Symposium, Proffered paper session, Educational Sessions, and EONS sessions.Insights driven through interaction with Presentors/Oncologists/Researchers on industry-affiliated Poster sessions.The agenda is to cover all pivotal trials, Late Breaking Abstracts (LBAs), efficacy data of first-in-class therapies targeting novel mutations, along with key company collaborations taking place on-site.Provide a pre-conference program to showcase the range of topics covered in each indication.Prioritizing abstracts highlighting the most pressing patient needs in terms of cancer screening (MRD testing and Early cancer detections), early-stage cancer treatment, and mutation/protein detection for making accurate therapy decisions for relapsed/refractory patients.Connecting with Keynote speakers to understand geographical variations and challenges in terms of cancer screening and treatment recommendations, thereby understanding the differences in clinical practices within a small community of physicians.Offer valuable information regarding upcoming biomarkers, potential applications, and market segments, while analyzing current trends in the utilization of biomarkers for both prevention and diagnosis.In-depth examinations of the latest updates from clinical trials and advancements in treatment approaches, coupled with shifts in treatment strategies resulting from the latest data and changes in conventional practices.In addition to coverage of key abstracts of potential therapy areas (Lung Cancer, Breast Cancer, Genitourinary Cancer, Gastrointestinal Cancer, Gynecologic Cancer, and Hematological Malignancies), tracking the latest advancements by diagnostic companies focussing on screening and surveillance through tumor/tissue and liquid biopsy.Keep a close watch and synthesize the information regarding the most recent successes and failures in potential fields.

Connect with our Oncology Subject Matter expert to understand how to leverage ESMO Conference Solutions for maximum benefit

Oncology Conference Coverage Services: DelveInsight’s Oncology Conference Coverage Services offer a thorough analysis of outcomes from major events like ASCO, ESMO, ASH, AACR, ASTRO, SOHO, SITC, the European CAR T-cell Meeting, and IASLC. This detailed examination provides businesses with essential insights for competitive intelligence and market trend forecasting, supporting the formulation of future strategies.

Oncology Portfolio Management: DelveInsight’s deep expertise in oncology distinguishes us, as we excel in understanding the complexities of the cancer field. Our core focus is on aligning with strategic goals, analyzing advancements in the oncology sector, assessing the current demands of the oncology market, and providing exceptional client services.

Rare Diseases Analysis: At DelveInsight, we are dedicated to providing essential reports that address the complexities of the rare cancer market. Our team of expert analysts diligently tracks the evolving developmental, regulatory, and commercial environments of competing products. We offer a range of services, including insightful conference evaluations and in-depth analyses of company progress and R&D activities, all designed to support the smooth development of oncology solutions tailored to our clients’ specific requirements.

Oncology Pipeline Assessment: Our oncology pipeline evaluation offers a comprehensive overview of cancer treatment options, clinical trials, and key areas within the cancer therapeutics field, all summarized in an accessible report format. The oncology-focused reports, available in our Report Store, provide in-depth insights into treatment strategies, mechanisms of action (MoAs), drug components, and launch plans for therapies in the late stages of development. This assessment enhances understanding of their launch timelines and strategic initiatives.

R&D Analysis: Our skilled research and development analyst specializes in the complexities of oncology, offering essential insights and advice to clients aiming to advance in oncological research and development. They utilize a methodical assessment approach, aligned with industry norms, to track the progress of each oncology drug in both pre-clinical and clinical stages. DelveInsight’s comprehensive oncological reports are crafted to reduce uncertainties and highlight overlooked areas, providing organizations with timely and strategic intelligence.

Stay tuned with DelveInsight’s team for all the latest updates and breakthroughs happening at ESMO 2024 and how the results are going to impact the treatment paradigm along with an analysis of the overall impact on the indication market landscape.

Get an exclusive glimpse of ESMO 2024 Annual Meeting Preview Content

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us
Shruti Thakur
info@delveinsight.com
+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/esmo-2024-stay-informed-with-real-time-coverage-and-analysis-from-delveinsight-302247541.html

SOURCE DelveInsight Business Research, LLP

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Husqvarna Group’s climate targets validated by the Science Based Targets initiative

Published

on

By

STOCKHOLM, May 11, 2026 /PRNewswire/ — Husqvarna Group’s greenhouse gas emissions reduction targets have been validated by the Science Based Targets initiative (SBTi), a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. This confirms alignment of the Group’s greenhouse gas emissions reduction targets with the SBTi Net-Zero Criteria.

The validation covers both Husqvarna Group’s net-zero target and updated near-term target, encompassing greenhouse gas emissions across Scope 1, 2 and 3. According to the validation by the SBTi, Husqvarna AB commits to achieve net-zero greenhouse gas emissions across its value chain by 2050, and to reduce absolute Scope 1, 2 and 3 greenhouse gas emissions by 60.28 percent by 2030 and by 90.0 percent by 2050, from a 2015 base year. This includes direct emissions from the Group’s own operations, indirect emissions from purchased energy, and the most material categories of value-chain emissions, where the majority of Husqvarna Group’s climate impact occurs.

“Having our climate targets validated by the Science Based Targets initiative is an important confirmation that Husqvarna Group’s climate targets are both ambitious and credible under the SBTi’s criteria. Sustainability is a long-standing strategic priority for Husqvarna Group, and this validation provides a clear, science-based pathway for our continued work to reduce emissions across the entire value chain,” says Glen Instone, CEO at Husqvarna Group.

The validated climate targets provide a framework for Husqvarna Group’s continued sustainability work and are implemented as part of the Group’s overall business strategy. The validation also strengthens transparency towards customers, investors and other stakeholders regarding Husqvarna Group’s long-term climate efforts. Further details on the Group’s climate targets, methodology, scope, base year and progress are available in Husqvarna Group’s Annual Report, accessible at www.husqvarnagroup.com.

More information about Husqvarna Group’s validated targets can be found on SBTi’s website, using search word Husqvarna AB.

For additional information, please contact:
Media
Henrik Sjöström, Head of external communication
+46 727 – 15 77 85
press@husqvarnagroup.com

Investors
Emelie Alm, Vice President Investor Relations
+46 705 – 14 64 14
ir@husqvarnagroup.com

Husqvarna Group

Husqvarna Group is a global leader in innovative solutions for managing forests, parks, and gardens, as well as equipment and diamond tools for the construction industry. With an innovative mindset, we are dedicated to delivering high-quality solutions ranging from robotic mowers to chainsaws, watering systems and power cutters, with a strong focus on our customers and future generations.

Founded in the Swedish town Huskvarna in 1689, we have been pioneers in our business for more than three centuries. Today, we are mainly operating under the global Husqvarna and Gardena brands, serving consumers and professionals in over 100 countries through direct sales, dealers, and retailers. Headquartered in Stockholm, Sweden, Husqvarna Group employs approximately 11,900 people in 40 countries and reported net sales of SEK 46.6 billion in 2025. Husqvarna Group is listed on Nasdaq Stockholm.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/husqvarna-group/r/husqvarna-group-s-climate-targets-validated-by-the-science-based-targets-initiative,c4346217

The following files are available for download:

https://mb.cision.com/Main/996/4346217/4083686.pdf

Husqvarna Group’s climate targets validated by the Science Based Targets initiative

 

View original content:https://www.prnewswire.com/news-releases/husqvarna-groups-climate-targets-validated-by-the-science-based-targets-initiative-302767983.html

SOURCE Husqvarna Group

Continue Reading

Technology

Planning a Group Visit to Medtec Shanghai: A Corporate Buyer’s Guide

Published

on

By

SHANGHAI, May 11, 2026 /PRNewswire/ — Sourcing complex medical device components is rarely a solo job. Building a secure supply chain requires direct input from product engineering, quality control, and executive procurement teams. Sending your entire group to the Medtec China exhibition ensures that all departments align perfectly on crucial manufacturing decisions.

As the premier event for medical device research, development, and manufacturing, this gathering provides the ideal environment for corporate buyers to evaluate global suppliers. Mark your calendar for September 1-3, 2026, at the Shanghai New International Expo Center (Halls N1-N4). You can secure free early bird tickets by registering your team between April 1 and August 30. If you wait until the event begins, on-site registration will cost 100 RMB per person. Register your team today to claim your free passes, explore groundbreaking innovations, and streamline your next major product launch.

The Strategic Advantage of Attending as a Team

When you step into a massive Shanghai medical expo, the sheer scale of the event can easily overwhelm a single buyer. Spanning multiple massive exhibition halls, the floor features thousands of advanced raw materials, heavy machinery displays, and compliance software solutions.

Divide and Conquer the Show Floor

Bringing a corporate group allows you to multiply your sourcing power. A single buyer simply cannot evaluate a new biocompatible polymer supplier while simultaneously watching a live demonstration of robotic assembly arms on the other side of the convention center. By sending a specialized team, you can divide and conquer. While your procurement manager negotiates bulk pricing for extrusion tubing, your lead mechanical engineer can inspect smart factory automation tools in a completely different pavilion.

Cross-Functional Vendor Evaluation

Approving a new manufacturing partner requires multiple distinct perspectives. An engineer must verify mechanical tolerances, a quality control specialist needs to review ISO 13485 certifications, and a buyer has to assess minimum order quantities. When your team evaluates a vendor together at the booth, you can ask all these critical questions simultaneously. This unified approach prevents the endless email chains and internal delays that typically plague international sourcing.

How to Coordinate a Seamless Corporate Visit

Planning a productive overseas trip for multiple stakeholders requires strict organization. If your team arrives without a cohesive plan, you risk duplicating efforts and missing out on key suppliers.

Set Clear Group Sourcing Goals

Before you book any flights or hotels, hold a comprehensive pre-trip planning meeting. Identify the specific bottlenecks currently slowing down your production lines. Create a master list of required components and delegate exact sourcing targets to specific team members.

Define technical requirements: Gather all CAD drawings, material specifications, and regulatory benchmarks.Establish budget limits: Ensure the procurement team knows the exact target price points for raw materials and contract manufacturing services.Identify target exhibitors: Review the official online exhibitor list together and highlight the companies your team absolutely must meet.

Manage Logistics and Registrations Early

Ensure every member of your group registers during the free early bird window to avoid unnecessary on-site fees. When booking travel, secure hotel accommodations as close to the Shanghai New International Expo Center as possible. Minimizing morning transit times keeps your team energized and focused on the highly demanding work of vendor negotiation.

Tips for Maximizing Team Productivity at the Event

Once your group arrives at the exhibition, you must balance individual exploration with coordinated team strategy. Protect your time to secure the highest possible return on your travel investment.

Assign Specific Engineering Pavilions

The exhibition floor groups vendors by their specific engineering capabilities. Leverage this logical layout by assigning your staff to the zones that match their daily expertise:

R&D Engineers: Focus on the advanced materials pavilions, searching for shape-memory alloys, specialized ceramics, and rapid prototyping services.Quality Assurance Experts: Dedicate time to the testing and metrology sectors, evaluating visual inspection cameras and compliance management software.Supply Chain Managers: Target the contract manufacturing and packaging halls to negotiate lead times and sterile delivery options.

Schedule Daily Debriefs

Continuous communication prevents team members from operating in silos. Schedule a mandatory debriefing session at the end of each day, either over dinner or at a quiet coffee shop. Use this time to share findings, compare notes on promising new suppliers, and identify any overlapping interests. If an engineer finds a highly capable components manufacturer, the entire team can plan a joint follow-up meeting at that booth for the following morning to finalize a capability audit.

Prepare Your Team for Manufacturing Success

Attending a major medical device exhibition as a unified corporate group entirely transforms your procurement strategy. It eliminates internal communication barriers, speeds up the vendor vetting process, and helps you build a much more resilient supply chain.

Do not let your competitors outpace your manufacturing capabilities. Review your upcoming project pipelines, assemble your core sourcing team, and secure your group registration for Medtec China 2026. Empower your staff with the tools and contacts they need to secure the best manufacturing partnerships in the global market.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/planning-a-group-visit-to-medtec-shanghai-a-corporate-buyers-guide-302767999.html

SOURCE Medtec China

Continue Reading

Technology

Share buybacks in Ericsson during the period May 4 – May 8, 2026

Published

on

By

STOCKHOLM, May 11, 2026 /PRNewswire/ — During the period May 4 – May 8, 2026, Telefonaktiebolaget LM Ericsson (publ) (“Ericsson”) (LEI code 549300W9JLPW15XIFM52) repurchased own Class B shares (ISIN: SE0000108656) as follows:

Date

Aggregated daily volume (number of shares)

Weighted average share price per day (SEK)

Total daily transaction value (SEK)

2026-05-04

250,000

108.3303

27,082,575.00

2026-05-05

800,000

110.8867

88,709,360.00

2026-05-06

500,000

111.3745

55,687,250.00

2026-05-07

500,000

110.2140

55,107,000.00

2026-05-08

600,000

109.0358

65,421,480.00

Total

2,650,000

110.1916

292,007,665.00

The share repurchases are a part of the share buyback program of up to SEK 15,000,000,000 which Ericsson announced on April 16, 2026, and which runs between April 23, 2026, and March 31, 2027, at the latest. The Board of Directors intends to propose to the 2027 Annual General Meeting that the repurchased shares, other than those used to fulfil Ericsson’s obligations under its share-related incentive programs, are cancelled.

The share buyback program is executed in accordance with the Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse (“MAR”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing MAR (“the Safe Harbour Regulation”).

All acquisitions have been carried out on Nasdaq Stockholm by Goldman Sachs Bank Europe SE on behalf of Ericsson. A full breakdown of the transactions is attached to this announcement.

Following the repurchases above, Ericsson’s holding of treasury stock amounts to 46,763,592 Class B shares. There are in total 3,371,351,735 shares in Ericsson, 261,755,983 shares of Class A and 3,109,595,752 shares of Class B.

NOTES TO EDITORS:

FOLLOW US:

Subscribe to Ericsson press releases
Subscribe to Ericsson blog posts
https://x.com/ericsson
https://www.facebook.com/ericsson
https://www.linkedin.com/company/ericsson

MORE INFORMATION AT:
Ericsson Newsroom
media.relations@ericsson.com (+46 10 719 69 92)
investor.relations@ericsson.com (+46 10 719 00 00)

FOR FURTHER INFORMATION, PLEASE CONTACT:
Contact person
Investors
Daniel Morris, Vice President, Head of Investor Relations
Phone: +44 7386 657217
E-mail: investor.relations@ericsson.com

Lena Häggblom, Director, Investor Relations
Phone: +46 72 593 27 78
E-mail: lena.haggblom@ericsson.com

Alan Ganson, Director, Investor Relations
Phone: +46 70 267 27 30
E-mail: alan.ganson@ericsson.com

Media
Ralf Bagner, Head of Media Relations
Phone: +46761284789
E-mail: ralf.bagner@ericsson.com

ABOUT ERICSSON:
Ericsson’s high-performing, programmable networks provide connectivity for billions of people every day. For 150 years, we’ve been pioneers in creating technology for communication. We offer mobile communication and connectivity solutions for service providers and enterprises. Together with our customers and partners, we make the digital world of tomorrow a reality. www.ericsson.com

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-may-4—may-8–2026,c4346730

The following files are available for download:

https://mb.cision.com/Main/15448/4346730/4085654.pdf

Share buybacks in Ericsson during the period May 4 – May 8, 2026

https://mb.cision.com/Public/15448/4346730/b58b8bdcbcebf5e9.xlsx

Daily Ericsson Share Buyback Report

 

View original content:https://www.prnewswire.com/news-releases/share-buybacks-in-ericsson-during-the-period-may-4–may-8-2026-302768000.html

SOURCE Ericsson

Continue Reading

Trending